CLCN1 and myotonic dystrophy type 1: However, these findings conflict with functional data, shown here with CRISPR-based gene editing (Fig. 3) or previously with splice-shifting E7a splicing specific ASOs12, that were capable of restoring WT or even supr- maximal levels of ClC-1 function in DM1 mouse models.